Early investigational drugs targeting tau protein for the treatment of Alzheimer’s disease
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Early investigational drugs targeting tau protein for the treatment of Alzheimer’s disease
Authors
Keywords
-
Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 24, Issue 10, Pages 1355-1360
Publisher
Informa Healthcare
Online
2016-02-13
DOI
10.1517/13543784.2015.1075002
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Human secreted tau increases amyloid-beta production
- (2015) Jessica Bright et al. NEUROBIOLOGY OF AGING
- Long-Term Lithium Treatment Reduces Glucose Metabolism in the Cerebellum and Hippocampus of Nondemented Older Adults: An [18F]FDG-PET Study
- (2014) Orestes V. Forlenza et al. ACS Chemical Neuroscience
- Neuroprotective Effects of Lithium: Implications for the Treatment of Alzheimer’s Disease and Related Neurodegenerative Disorders
- (2014) O. V. Forlenza et al. ACS Chemical Neuroscience
- Neuronal uptake of tau/pS422 antibody and reduced progression of tau pathology in a mouse model of Alzheimer‘s disease
- (2014) Ludovic Collin et al. BRAIN
- Investigational drugs in Alzheimer's disease: current progress
- (2014) Camryn Berk et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Tau-Based Therapeutic Approaches for Alzheimer's Disease - A Mini-Review
- (2014) Allal Boutajangout et al. GERONTOLOGY
- Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial
- (2014) Adam L Boxer et al. LANCET NEUROLOGY
- The NAP motif of activity-dependent neuroprotective protein (ADNP) regulates dendritic spines through microtubule end binding proteins
- (2014) S Oz et al. MOLECULAR PSYCHIATRY
- First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model
- (2014) Eva Kontsekova et al. Alzheimers Research & Therapy
- Tau-aggregation inhibitor therapy for Alzheimer's disease
- (2013) Claude M. Wischik et al. BIOCHEMICAL PHARMACOLOGY
- NAP Alpha-Aminoisobutyric Acid (IsoNAP)
- (2013) Illana Gozes et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Alzheimer disease therapy—moving from amyloid-β to tau
- (2013) Ezio Giacobini et al. Nature Reviews Neurology
- Efficacy and Safety of A Liposome-Based Vaccine against Protein Tau, Assessed in Tau.P301L Mice That Model Tauopathy
- (2013) Clara Theunis et al. PLoS One
- Targeting Phospho-Ser422 by Active Tau Immunotherapy in the THYTau22 Mouse Model: A Suitable Therapeutic Approach
- (2012) Nadege Zommer et al. Current Alzheimer Research
- Does Lithium Prevent Alzheimerʼs Disease?
- (2012) Orestes V. Forlenza et al. DRUGS & AGING
- The Microtubule-Stabilizing Agent, Epothilone D, Reduces Axonal Dysfunction, Neurotoxicity, Cognitive Deficits, and Alzheimer-Like Pathology in an Interventional Study with Aged Tau Transgenic Mice
- (2012) B. Zhang et al. JOURNAL OF NEUROSCIENCE
- Chronic Divalproex Sodium to Attenuate Agitation and Clinical Progression of Alzheimer Disease
- (2011) Pierre N. Tariot ARCHIVES OF GENERAL PSYCHIATRY
- Valproate reduces tau phosphorylation via cyclin-dependent kinase 5 and glycogen synthase kinase 3 signaling pathways
- (2011) Jiang-Ping Hu et al. BRAIN RESEARCH BULLETIN
- Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial
- (2011) Orestes V. Forlenza et al. BRITISH JOURNAL OF PSYCHIATRY
- NAP (Davunetide) Provides Functional and Structural Neuroprotection
- (2011) Illana Gozes CURRENT PHARMACEUTICAL DESIGN
- A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S )-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer’s disease
- (2011) Tomohiro Onishi et al. JOURNAL OF NEUROCHEMISTRY
- Chronic divalproex sodium use and brain atrophy in Alzheimer disease
- (2011) A. S. Fleisher et al. NEUROLOGY
- Epothilone D Improves Microtubule Density, Axonal Integrity, and Cognition in a Transgenic Mouse Model of Tauopathy
- (2010) K. R. Brunden et al. JOURNAL OF NEUROSCIENCE
- Alzheimer's Disease
- (2010) Henry W. Querfurth et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started